Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Treatment Period 1	STARTED	Bimatoprost 0.03% Eye Drops	0
Treatment Period 1	STARTED	Latanoprost 0.005% Eye Drops	586
Treatment Period 1	COMPLETED	Bimatoprost 0.03% Eye Drops	0
Treatment Period 1	COMPLETED	Latanoprost 0.005% Eye Drops	586
Treatment Period 1	NOT COMPLETED	Bimatoprost 0.03% Eye Drops	0
Treatment Period 1	NOT COMPLETED	Latanoprost 0.005% Eye Drops	0
Treatment Period 2	STARTED	Bimatoprost 0.03% Eye Drops	270
Treatment Period 2	STARTED	Latanoprost 0.005% Eye Drops	273
Treatment Period 2	COMPLETED	Bimatoprost 0.03% Eye Drops	261
Treatment Period 2	COMPLETED	Latanoprost 0.005% Eye Drops	266
Treatment Period 2	NOT COMPLETED	Bimatoprost 0.03% Eye Drops	9
Treatment Period 2	NOT COMPLETED	Latanoprost 0.005% Eye Drops	7

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00541242/flow